Company Overview of Tapestry Pharmaceuticals, Inc.
Key Executives for Tapestry Pharmaceuticals, Inc.
|Leonard P. Shaykin||20 Relationships||Chairman of the Board and Chief Executive Officer||70|
|Martin M. Batt||No Relationships||Chief Operating Officer and Senior Vice President||73|
Tapestry Pharmaceuticals, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Leonard P. Shaykin||20 Relationships||Tapestry Pharmaceuticals, Inc.||70|
|Paul A. Bunn Jr., M.D.||86 Relationships||Tapestry Pharmaceuticals, Inc.||--|
|George L. Gould J.D., Llm., Ph.D.||26 Relationships||Aspen Aerogels, Inc.||78|
|Valentino J. Stella Ph.D.||28 Relationships||Orbis Biosciences, Inc.||--|
|Elliot M. Maza J.D., CPA||31 Relationships||Intellect Neurosciences, Inc.||60|
Tapestry Pharmaceuticals, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee J.D., CPA||Elliot M. Maza||31 Relationships||3 Executives|
|Nominating Committee J.D., Llm., Ph.D.||George L. Gould||26 Relationships||1 Executives|
|Corporate Governance Committee J.D., Llm., Ph.D.||George L. Gould||26 Relationships||1 Executives|
|Advisory Board Ph.D.||Valentino J. Stella||28 Relationships||14 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options||$720.0K|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.